Screener
Haemonetics HAE Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
Based on trailing twelve months.
The source filing: Haemonetics’s 10-Q, filed February 5, 2026. Open the filing →
- Filed
- Feb 5, 2026, 6:05 AM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q4 2025
- Accession
- 0000313143-26-000010
FAQ
- What is Haemonetics's return on invested capital?
- Haemonetics (HAE) reported return on invested capital of 10.8% in Q4 2025.
- How has Haemonetics's return on invested capital changed year-over-year?
- Haemonetics's return on invested capital increased by 30.3% year-over-year, from 8.3% to 10.8%.
- What is the long-term trend for Haemonetics's return on invested capital?
- Over 4 years (2021 to 2025), Haemonetics's return on invested capital has grown at a 5.7% compound annual growth rate (CAGR), from 8.1% to 10.2%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Haemonetics's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude